Hinge Bio

Drug Discovery · Burlingame, CA · Founded 2015 · Privately Held (backing)

Operator of a biotech company intended to work for the development of a new class of flexible, extendible, and cooperatively binding therapeutics and diagnostics. Hinge Bio is based in Burlingame, CA and was founded in 2015. It was valued at $46 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $66.8 million across 4 recorded rounds; the latest was a $30.6 million early-stage round in Dec 2024.

PMV mark · valuation
$46.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$66.8M
Last round
Early Stage VC
Dec 2024

Who backs Hinge Bio?

13 investors
InvestorType
US National Science FoundationOther
Springboard EnterprisesOther
United States Department of War—
Evolution VC PartnersVenture capital
Baruch Future VenturesFamily office
Ridgeback CapitalVenture capital
Point72 Asset ManagementAsset manager
Agent Capital—
Altamont Pharmaceutical Holdings—
InVivium Capital—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Hinge Bio investors

13 investors are on record for Hinge Bio, including US National Science Foundation, Springboard Enterprises, United States Department of War and Evolution VC Partners. The early-stage round in Dec 2024 drew 82 investors.

Free account
More of Hinge Bio with a free account
  • ·The complete investor list: 13 names
  • ·Watch Hinge Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Hinge Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View